» Articles » PMID: 38932210

Human Cytomegalovirus Dysregulates Cellular Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases and Sonic Hedgehog Pathway Proteins in Neural Astrocyte and Placental Models

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2024 Jun 27
PMID 38932210
Authors
Affiliations
Soon will be listed here.
Abstract

Human cytomegalovirus (CMV) infection is the leading non-genetic cause of congenital malformation in developed countries, causing significant fetal injury, and in some cases fetal death. The pathogenetic mechanisms through which this host-specific virus infects then damages both the placenta and the fetal brain are currently ill-defined. We investigated the CMV modulation of key signaling pathway proteins for these organs including dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and Sonic Hedgehog (SHH) pathway proteins using human first trimester placental trophoblast (TEV-1) cells, primary human astrocyte (NHA) brain cells, and CMV-infected human placental tissue. Immunofluorescence demonstrated the accumulation and re-localization of SHH proteins in CMV-infected TEV-1 cells with Gli2, Ulk3, and Shh re-localizing to the CMV cytoplasmic virion assembly complex (VAC). In CMV-infected NHA cells, DYRK1A re-localized to the VAC and DYRK1B re-localized to the CMV nuclear replication compartments, and the SHH proteins re-localized with a similar pattern as was observed in TEV-1 cells. Western blot analysis in CMV-infected TEV-1 cells showed the upregulated expression of Rb, Ulk3, and Shh, but not Gli2. In CMV-infected NHA cells, there was an upregulation of DYRK1A, DYRK1B, Gli2, Rb, Ulk3, and Shh. These in vitro monoculture findings are consistent with patterns of protein upregulation and re-localization observed in naturally infected placental tissue and CMV-infected ex vivo placental explant histocultures. This study reveals CMV-induced changes in proteins critical for fetal development, and identifies new potential targets for CMV therapeutic development.

References
1.
Hamilton S, Marschall M, Rawlinson W . Investigational Antiviral Therapy Models for the Prevention and Treatment of Congenital Cytomegalovirus Infection during Pregnancy. Antimicrob Agents Chemother. 2020; 65(1). PMC: 7927873. DOI: 10.1128/AAC.01627-20. View

2.
Wu S, Tan K, Chen H, Beh T, Yeo H, Ng S . Enhanced production of neuroprogenitors, dopaminergic neurons, and identification of target genes by overexpression of sonic hedgehog in human embryonic stem cells. Stem Cells Dev. 2011; 21(5):729-41. DOI: 10.1089/scd.2011.0134. View

3.
Deng X, Hu J, Ewton D, Friedman E . Mirk/dyrk1B kinase is upregulated following inhibition of mTOR. Carcinogenesis. 2014; 35(9):1968-76. PMC: 4146409. DOI: 10.1093/carcin/bgu058. View

4.
Singh R, Lauth M . Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control. J Dev Biol. 2018; 5(4). PMC: 5831797. DOI: 10.3390/jdb5040013. View

5.
Boppana S, Fowler K, Vaid Y, Hedlund G, Stagno S, Britt W . Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 1997; 99(3):409-14. DOI: 10.1542/peds.99.3.409. View